Journal Article10.1016/J.BIOPSYCH.2005.03.019
Open-Label, 8-Week Trial of Olanzapine and Risperidone for the Treatment of Bipolar Disorder in Preschool-Age Children
Joseph Biederman,Eric Mick,Paul Hammerness,Theresa Harpold,Megan Aleardi,Meghan Dougherty,Janet Wozniak +6 more
168
TL;DR: Treatment with risperidone or olanzapine may result in a rapid reduction of symptoms of mania in preschool children with BPD, suggesting a pressing need to identify additional safe and effective treatments for the management of BPD in this high-risk population.
read more
About: This article is published in Biological Psychiatry. The article was published on 01 Oct 2005. The article focuses on the topics: Atypical antipsychotic & Olanzapine.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.
TL;DR: It is not clear whether the atypical forms of juvenile mania and the classic adult form of the disorder represent the same illness, and the question of diagnostic continuity has important treatment and prognostic implications.
654
Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: update 2007
Lakshmi N. Yatham,Sidney H. Kennedy,Claire O'Donovan,Sagar V. Parikh,Glenda MacQueen,Roger S. McIntyre,Verinder Sharma,Serge Beaulieu +7 more
TL;DR: This update reviews new evidence since the previous publication and incorporates recommendations based on the most current evidence for treatment of various phases of bipolar disorder, and provides an expanded look at the prevalence, impact and management of comorbid conditions in patients with bipolar disorder.
337
Psychopharmacological Treatment for Very Young Children: Contexts and Guidelines
Mary Margaret Gleason,Helen L. Egger,Graham J. Emslie,Laurence L. Greenhill,Robert A. Kowatch,Alicia F. Lieberman,Joan L. Luby,Judith A. Owens,Lawrence Scahill,Michael S. Scheeringa,Brian Stafford,Brian K. Wise,Charles H. Zeanah +12 more
TL;DR: The developmental considerations related to preschool psychopharmacological treatment are reviewed, current evidence bases for specific disorders in early childhood are presented, and the recommended algorithms for medication use are described.
Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents.
TL;DR: Results from these pediatric studies indicate that adverse effect profiles differ among commonly used antipsychotics, but more detailed data are needed as information is lacking regarding carryover or withdrawal effects from prior medications and regarding the masking of effects by adjunctive treatments used to treat agitation, insomnia, or extrapyramidal symptoms and akathisia.
Treatment-emergent adverse events from selective serotonin reuptake inhibitors by age group: children versus adolescents.
Daniel J. Safer,Julie M. Zito +1 more
TL;DR: Children are particularly vulnerable to specific AEs from certain medications, such as SSRIs, and it is likely that the level of children's biological immaturity explains part of this phenomenon.
185
References
A rating scale for mania: reliability, validity and sensitivity.
TL;DR: The MRS score correlated highly with an independent global rating, and with scores of two other mania rating scales administered concurrently, and also correlated with the number of days of subsequent stay in hospital.
8.4K
Four Factor Index of Social Status [1975]
A.B. Hollingshead
- 01 Jan 1975
TL;DR: This paper is a 23-page photocopy of an unpublished working paper, with appendix and references, based on a monograph published in “Sociology: Foundations of Sociology, 2nd Ed.” (2003).
5.1K
A Double-blind, Randomized, Placebo-Controlled Trial of Fluoxetine in Children and Adolescents With Depression
Graham J. Emslie,A. John Rush,Warren A. Weinberg,Robert A. Kowatch,Carroll W. Hughes,Thomas J. Carmody,Jeanne Rintelmann +6 more
TL;DR: Fluoxetine was superior to placebo in the acute phase treatment of major depressive disorder in child and adolescent outpatients with severe, persistent depression, and complete remission of symptoms was rare.
1K
Trends in the prescribing of psychotropic medications to preschoolers.
TL;DR: In this paper, the prevalence of psychotropic medications for preschool-aged children with behavioral and emotional disorders was determined by analyzing three 1-year cross-sectional data sets (for the years 1991, 1993, and 1995).
873
Historical Development and Present Status of the Schedule for Affective Disorders and Schizophrenia for School-Age Children (K-SADS)
TL;DR: The K-SADS is a viable interview schedule to assess current, past, and lifetime diagnostic status in children and adolescents and has the potential to further aide in the validation of psychiatric disorders.
765